Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Change in Cash of -$2.8 million for Q1 2026, down 101.4% year-over-year from $198.8 million in Q1 2025, and down 665.29% quarter-over-quarter from -$363000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Change in Cash for 17 consecutive years, with -$2.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 101.4% year-over-year to -$2.8 million; the TTM figure through Mar 2026 stood at -$192.8 million (down 210.97% YoY), while the FY2025 annual figure was $8.8 million, up 125.82% from the prior year.
- Change in Cash declined to -$2.8 million in Q1 2026 per WHWK's latest filing, from -$363000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $198.8 million in Q1 2025 and bottomed at -$107.0 million in Q3 2025.
- Historically, Change in Cash has averaged -$6.7 million across 5 years, with a median of -$5.9 million in 2023.
- Annual changes were most pronounced in 2024 — Change in Cash tumbled 1753.98% — and 2025, when it jumped 2283.08%.
- Whitehawk Therapeutics' Change in Cash stood at -$95.8 million in 2022, then jumped by 93.83% to -$5.9 million in 2023, then surged by 68.44% to -$1.9 million in 2024, then surged by 80.56% to -$363000.0 in 2025, then slumped by 665.29% to -$2.8 million in 2026.
- Business Quant data shows WHWK's Change in Cash at -$2.8 million in Q1 2026, -$363000.0 in Q4 2025, and -$107.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 50.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.44 Mn |
| Mar 31, 2026 | -2.78 Mn |
| Dec 31, 2025 | -363,000.00 |
| Sep 30, 2025 | -107.01 Mn |
| Jun 30, 2025 | -82.63 Mn |
| Mar 31, 2025 | 198.84 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -12.64 Mn |
| Mar 31, 2024 | -9.11 Mn |
| Dec 31, 2023 | -5.92 Mn |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 34.12 Mn |
| Mar 31, 2023 | -4.97 Mn |
| Dec 31, 2022 | -95.80 Mn |
| Sep 30, 2022 | 16.08 Mn |
| Jun 30, 2022 | -11.05 Mn |
| Mar 31, 2022 | -19.14 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | 149.70 Mn |